Abstract
The prevalence of the internalization-associated prtF1 gene was studied in 837 isolates of Streptococcus pyogenes obtained from 713 pediatric patients presenting with acute pharyngotonsillitis before and after antibiotic therapy. Its association with macrolide resistance and with bacteriological treatment failure was determined. The bacterial population isolated from baseline pharyngeal swabs showed an overall prtF1 positivity rate of 33%. A higher prtF1 positivity was found among erythromycin-resistant strains (45%) showing, however, marked differences between the inducible (iMLS), constitutive (cMLS), and efflux pump (M) resistance phenotypes. The prevalence was statistically higher (p < 0.001) in strains belonging to iMLS (84%) and cMLS (67%) phenotypes as compared to the M phenotype (15%). Interestingly, the prevalence of the prtF1 gene was significantly lower (p = 0.04) in strains belonging to M resistance phenotype as compared to erythromycin-susceptible strains (28%). Failed bacterial eradication was demonstrated in 124 patients. The prtF1 positivity rate remained unchanged in strains isolated before and after therapy in patients treated with macrolides (9/54). On the other hand, the positivity rate for the prtF1 gene wa...Continue Reading
References
Jun 1, 1978·Antimicrobial Agents and Chemotherapy·T NishiuraM Kono
Mar 1, 1978·Antimicrobial Agents and Chemotherapy·Y MiyamotoS Nakatsuka
Jan 30, 1992·The New England Journal of Medicine·H SeppäläT Klaukka
Apr 1, 1990·The Journal of Antimicrobial Chemotherapy·G PhillipsN Young
Jan 1, 1987·The Pediatric Infectious Disease Journal·H C Dillon
Jul 1, 1985·The Journal of Antimicrobial Chemotherapy·J Duval
Nov 25, 1983·Science·A L KomaroffJ Schachter
Dec 1, 1993·The Journal of Antimicrobial Chemotherapy·H SeppäläP Huovinen
Jun 1, 1996·Journal of Chemotherapy·C CellesiG M Rossolini
Oct 1, 1996·Emerging Infectious Diseases·G CornagliaR Fontana
Jan 1, 1997·Microbial Drug Resistance : MDR : Mechanisms, Epidemiology, and Disease·C E CocuzzaR Fontana
Feb 19, 1998·Microbiology·Viacheslav KaterovArtem A Totolian
Jan 1, 1999·Lancet·R NeemanS Sela
Jan 5, 2000·Journal of Clinical Microbiology·A M GoodfellowG S Chhatwal
Dec 19, 2000·Infection and Immunity·S BeckertA Podbielski
Feb 15, 2001·The Journal of Infectious Diseases·C M BrandtG Haase
Apr 12, 2001·Molecular Microbiology·G MolinariA Podbielski
Jul 17, 2001·Lancet·A Podbielski, B Kreikemeyer
Jul 17, 2001·Lancet·B FacinelliP E Varaldo
Jul 21, 2001·International Journal of Antimicrobial Agents·G RondiniR Mattina
Oct 2, 2002·Journal of Clinical Microbiology·Xiaoming MaKunihiko Kobayashi
Citations
Jan 5, 2006·Current Microbiology·Simona BiancoDianella Savoia
Jun 28, 2005·Antimicrobial Agents and Chemotherapy·Maria HallerReinhard Berner
Jun 19, 2010·International Journal of Pediatric Otorhinolaryngology·Gianluca AveronoPaolo Aluffi
Aug 22, 2008·European Journal of Clinical Microbiology & Infectious Diseases : Official Publication of the European Society of Clinical Microbiology·Y TakayamaT Akahoshi
Oct 30, 2007·Journal of Medical Microbiology·Maria A OliverSebastián Albertí
Jun 3, 2021·Journal of Clinical Medicine·Gilbert DondersWerner Mendling